Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified Clinical Trials in Rochester, Minnesota

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms